Health TrialsbyHealthPanel

Indiana University Gastrointestinal Motility Diagnosis Registry

ConditionsEosinophilic EsophagitisGastroesophageal Reflux Disease (GERD)GastroparesisFunctional VomitingIrritable Bowel Syndrome (IBS)ConstipationChronic Intestinal Pseudo-obstructionFecal IncontinenceSmall Intestinal Bacterial Overgrowth
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIndiana University

About this trial

Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology

Carries a diagnosis of GI motility disorder based on the diagnostic criteria listed in table

Disqualifiers

None

Trial population

All Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • no intervention

    Other intervention

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Identification of patients by accurate motility diagnosis

Motility diagnosis will be made by physicians with specialized in GI Motility, based on consensus diagnostic criteria. The information gathered from the database will be used to help promote future clinical development and research in GI motility disorders.

Time frame
.through study completion, an average of 10 years

Secondary outcomes

1

Patient Reported Outcome (PRO) Measurements in Patients with Small Intestinal Bacterial Overgrowth (SIBO)

SIBO-disease specific patient questionnaire will be compared between patients with aerodigestive tract SIBO and coliform SIBO

Time frame
through study completion, an average of 10 years
2

Patient Reported Outcome (PRO) Measurements in Patients with Gastroparesis

Patient Assessment of GI - Symptom (PAGI-SYM) scores will be compared between patients with emesis-predominant, dyspeptic-predominant, and regurgitation-predominant gastroparesis.

Time frame
through study completion, an average of 10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Indiana University

Lead sponsor

Source ClinicalTrials.gov
Apply now